InsiderClue
Insiders · Profile

Waltermire Robert E.

Senior VP, Chief Pharma Dev. at MADRIGAL PHARMACEUTICALS. Filing since 28 Feb 2023. CIK 0001876996

Company
Date
Role
Action
Shares
Amount
Of holding
MDGL MADRIGAL PHARMACEUTICALS, INC.
5 Mar 2025
Senior VP, Chief Pharma Dev.
Sold at will
14,113
$4.82M
79.1%
MDGL MADRIGAL PHARMACEUTICALS, INC.
28 Feb 2025
Senior VP, Chief Pharma Dev.
Sold at will
1,227
$418.49K
24.8%
MDGL MADRIGAL PHARMACEUTICALS, INC.
24 Jan 2025
Senior VP, Chief Pharma Dev.
Sold at will
103
$34.53K
2.0%
MDGL MADRIGAL PHARMACEUTICALS, INC.
17 Jan 2025
Senior VP, Chief Pharma Dev.
Sold at will
442
$120.85K
8.0%
MDGL MADRIGAL PHARMACEUTICALS, INC.
14 Jun 2024
Senior VP, Chief Pharma Dev.
Sold at will
1,900
$532.00K
25.7%
MDGL MADRIGAL PHARMACEUTICALS, INC.
12 Jun 2024
Senior VP, Chief Pharma Dev.
Sold at will
2,000
$570.00K
26.7%
MDGL MADRIGAL PHARMACEUTICALS, INC.
21 May 2024
Senior VP, Chief Pharma Dev.
Sold at will
1,036
$239.67K
15.9%
MDGL MADRIGAL PHARMACEUTICALS, INC.
15 Dec 2023
Senior VP, Chief Pharma Dev.
Sold at will
2,000
$477.00K
26.1%
MDGL MADRIGAL PHARMACEUTICALS, INC.
14 Dec 2023
Senior VP, Chief Pharma Dev.
Sold at will
2,000
$465.00K
26.1%
MDGL MADRIGAL PHARMACEUTICALS, INC.
13 Dec 2023
Senior VP, Chief Pharma Dev.
Sold at will
2,500
$563.50K
30.6%
MDGL MADRIGAL PHARMACEUTICALS, INC.
12 Dec 2023
Senior VP, Chief Pharma Dev.
Sold at will
1,300
$283.20K
18.7%
MDGL MADRIGAL PHARMACEUTICALS, INC.
1 Mar 2023
Senior VP, Chief Pharma Dev.
Sold, plan not stated
5,000
$1.37M
46.9%
MDGL MADRIGAL PHARMACEUTICALS, INC.
28 Feb 2023
Senior VP, Chief Pharma Dev.
Sold, plan not stated
5,000
$1.36M
46.9%
13 decisions on file.